Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study

Anna R. Giuliano, Robin B Harris, Rebecca L. Sedjo, Susie Baldwin, Denise Roe, Mary R. Papenfuss, Martha Abrahamsen, Paula Inserra, Sandra Olvera, Kenneth D Hatch

Research output: Contribution to journalArticle

225 Citations (Scopus)

Abstract

The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 Women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at ∼4 and ∼10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had ≥ 1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).

Original languageEnglish (US)
Pages (from-to)462-469
Number of pages8
JournalJournal of Infectious Diseases
Volume186
Issue number4
DOIs
StatePublished - Aug 15 2002

Fingerprint

Papillomavirus Infections
Women's Health
Incidence
Gynecological Examination
Human papillomavirus 16
Confidence Intervals
Infection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Incidence, prevalence, and clearance of type-specific human papillomavirus infections : The Young Women's Health Study. / Giuliano, Anna R.; Harris, Robin B; Sedjo, Rebecca L.; Baldwin, Susie; Roe, Denise; Papenfuss, Mary R.; Abrahamsen, Martha; Inserra, Paula; Olvera, Sandra; Hatch, Kenneth D.

In: Journal of Infectious Diseases, Vol. 186, No. 4, 15.08.2002, p. 462-469.

Research output: Contribution to journalArticle

Giuliano, Anna R. ; Harris, Robin B ; Sedjo, Rebecca L. ; Baldwin, Susie ; Roe, Denise ; Papenfuss, Mary R. ; Abrahamsen, Martha ; Inserra, Paula ; Olvera, Sandra ; Hatch, Kenneth D. / Incidence, prevalence, and clearance of type-specific human papillomavirus infections : The Young Women's Health Study. In: Journal of Infectious Diseases. 2002 ; Vol. 186, No. 4. pp. 462-469.
@article{a80de4351d4a4219b406b818806834bc,
title = "Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study",
abstract = "The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 Women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at ∼4 and ∼10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9{\%} per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had ≥ 1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95{\%} confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).",
author = "Giuliano, {Anna R.} and Harris, {Robin B} and Sedjo, {Rebecca L.} and Susie Baldwin and Denise Roe and Papenfuss, {Mary R.} and Martha Abrahamsen and Paula Inserra and Sandra Olvera and Hatch, {Kenneth D}",
year = "2002",
month = "8",
day = "15",
doi = "10.1086/341782",
language = "English (US)",
volume = "186",
pages = "462--469",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Incidence, prevalence, and clearance of type-specific human papillomavirus infections

T2 - The Young Women's Health Study

AU - Giuliano, Anna R.

AU - Harris, Robin B

AU - Sedjo, Rebecca L.

AU - Baldwin, Susie

AU - Roe, Denise

AU - Papenfuss, Mary R.

AU - Abrahamsen, Martha

AU - Inserra, Paula

AU - Olvera, Sandra

AU - Hatch, Kenneth D

PY - 2002/8/15

Y1 - 2002/8/15

N2 - The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 Women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at ∼4 and ∼10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had ≥ 1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).

AB - The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 Women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at ∼4 and ∼10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had ≥ 1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).

UR - http://www.scopus.com/inward/record.url?scp=0037103398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037103398&partnerID=8YFLogxK

U2 - 10.1086/341782

DO - 10.1086/341782

M3 - Article

C2 - 12195372

AN - SCOPUS:0037103398

VL - 186

SP - 462

EP - 469

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -